Susquehanna International Group, LLP Enanta Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	SELL	$38.82 - $54.59 $788,046 - $1.11 Million	-20,300 Reduced 30.95%	45,300 $1.83 Million
Q4 2022 Feb 14, 2023	SELL	$40.77 - $53.73 $265,005 - $349,245	-6,500 Reduced 9.02%	65,600 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $1.55 Million - $2.28 Million	32,000 Added 79.8%	72,100 $3.74 Million
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $617,706 - $1.25 Million	16,200 Added 67.78%	40,100 $1.9 Million
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $5,606 - $7,411	-100 Reduced 0.42%	23,900 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $403,273 - $652,379	6,700 Added 38.73%	24,000 $1.8 Million
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $344,568 - $492,660	8,400 Added 94.38%	17,300 $983,000
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $1.66 Million - $2.18 Million	-39,700 Reduced 81.69%	8,900 $439,000
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $312,930 - $359,694	-5,400 Reduced 10.0%	48,600 $3 Million
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $1.57 Million - $2.3 Million	26,100 Added 93.55%	54,000 $3.24 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $1.3 Million - $1.56 Million	16,000 Added 134.45%	27,900 $2.35 Million
Q1 2019 May 15, 2019	SELL	$69.08 - $105.66 $2.47 Million - $3.77 Million	-35,700 Reduced 75.0%	11,900 $1.14 Million
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $19,623 - $25,395	-300 Reduced 0.63%	47,600 $3.37 Million
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $615,312 - $909,864	7,200 Added 17.69%	47,900 $4.09 Million
Q2 2018 Aug 14, 2018	BUY	$81.85 - $120.51 $1.19 Million - $1.75 Million	14,500 Added 55.34%	40,700 $4.72 Million
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $932,351 - $1.48 Million	16,100 Added 159.41%	26,200 $2.12 Million
Q4 2017 Feb 14, 2018	SELL	$45.65 - $59.37 $415,415 - $540,267	-9,100 Reduced 47.4%	10,100 $593,000
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $727,871 - $898,560	19,200	19,200 $899,000

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$11.1 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$9.7 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$7.86 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$5.79 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account